Introduction
Neuromuscular function disturbances are a common feature in patients admitted to the ICU. While few patients are admitted because of a primary neuromuscular disease (NMD) with acute respiratory failure, 1,2 most patients admitted to the ICU due to different medical or surgical reasons develop ICU-acquired weakness (ICU-AW), [3] [4] [5] which is associated with weaning failure of mechanical ventilation. 6, 7 Weakness of the respiratory muscles leads to hypercapnic respiratory failure. 8, 9 The acute hypercapnic respiratory failure in NMD patients and the weaning failure in ICU-AW patients are attributable to the acute inspiratory muscles weakness or a relatively trivial increase in mechanical ventilatory load, such as mild airway obstruction, atelectasis, or infection. 6, 7 The contribution of the central respiratory drive in the respiratory failure in both situations has not been fully established yet.
The central respiratory drive can be evaluated measuring the hypercapnic drive response as a change in the airway occlusion pressure 0.1 second after the start of inspiration (P 0.1 ) induced by the increase in PaCO 2 . While some studies in NMD found that the hypercapnic drive response is usually preserved in stable patients 10, 11 and in patients with acute respiratory failure, 12 a reduced hypercapnic drive response in stable myasthenia gravis patients, compared to normal subjects, has also been described. 13 The depressed central respiratory drive in some NMD patients has also been associated with a poor relationship between respiratory muscle strength and the level of PaCO 2 , 14, 15 with the occurrence of daytime hypersomnolence, 14 or with central hypoventilation. 16 In ICU-AW patients who fail weaning trials, the central respiratory drive has not yet been studied.
We evaluated 2 different models of neuromuscular dysfunction, one at admission (NMD group), and the other acquired during ICU stay (ICU-AW group). The objective of this prospective study was to compare the CO 2 response and the duration of weaning from mechanical ventilation between a group of NMD patients and a group of patients with quadriplegia due to ICU-AW.
Methods

Subjects
In 2 medical-surgical ICUs we prospectively studied non-consecutive subjects mechanically ventilated due to acute hypercapnic respiratory failure secondary to NMD (16 subjects) or with weaning failure secondary to ICU-AW quadriplegia (26 subjects). The study was conducted from July 2004 to November 2009, and was approved by the review boards of both hospitals. Informed consent was obtained in all cases from the subject or closest relative.
The different NMDs were diagnosed by clinical, physical examination, electromyogram, imaging, and laboratory tests. 2 According to the Brussels round table conference, 3 the ICU-AW group included subjects who developed weakness in the course of treatment of an acute illness syndrome such as sepsis and/or respiratory failure. Subjects with quadriplegia due to ICU-AW were identified in awakening subjects after the acute phase of critical illness by using the simple bedside limb muscle strength score of the Medical Research Council. 17 In these subjects, quadriplegia was considered when 12 muscle groups in upper (wrist extension, elbow flexion, and shoulder abduction) and lower extremities (dorsiflexion of the foot, knee extension, hip flexion) were tested showing no muscular contraction or barely detectable flicker or trace of contraction.
Protocol
Subjects were studied when the physician in charge considered that they were clinically stable and fulfilled criteria for a spontaneous breathing trial. These criteria included that the subject was hemodynamically stable, awake without sedation, and able to obey oral commands, core temperature below 38.3°C, and had a PaO 2 /FIO 2 above 150 mm Hg with a PEEP of Յ 8 cm H 2 O. 18 Patients were not studied if they had a diagnosis of COPD.
When the subjects were clinically stable and ready for a spontaneous breathing trial, respiratory neuromuscular function was evaluated by measurement of maximal inspiratory pressure (P Imax ), maximal expiratory pressure (P Emax ), and CO 2 response test. All these measurements were carried out in the semirecumbent position at 30°. We continuously recorded electrocardiogram, heart rate, pulse oximetry, and invasive systemic blood pressure.
Measurements and Procedures
Maximal Inspiratory and Expiratory Pressure. P Imax and P Emax were measured, after 1-2 min of spontaneous breathing, with an external pressure transducer, via a unidirectional valve (Hans Rudolph, Kansas City, Missouri) connected to the endotracheal tube. P Imax was obtained at residual volume by occluding the inspiratory port of the unidirectional valve, whereas P Emax was measured at total lung volume by occluding the expiratory port. 19 After 20 -25 seconds of occluded inspiration or expiration, the most negative or positive pressure values were recorded for P Imax or P Emax test. Two measurements were performed and the highest value was used for analysis.
CO 2 Response Test
To increase the CO 2 we used the method of the reinhalation of expired air, 20 -22 by inserting a 22 mm cor-
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Current knowledge
Respiratory muscle weakness in patients with neuromuscular disease or ICU-acquired weakness results in hypercapnia. Minor increases in ventilatory load in these patients can precipitate the need for mechanical ventilation or result in weaning failure. While the impact of respiratory muscle weakness in these patients is well known, the contribution of central respiratory drive is not well defined.
What this paper contributes to our knowledge
Subjects with acute hypercapnic respiratory failure secondary to neuromuscular disease had a reduced hypercapnic drive response, compared to subjects with ICU-acquired weakness. Reduced hypercapnic respiratory drive was associated with prolonged weaning from mechanical ventilation. Baseline values for CO 2 response test were obtained after applying 5 min of pressure support ventilation with a pressure of 7 cm H 2 O, without PEEP, and FIO 2 was set at 1.0 to prevent hypoxemia for subjects' security and to avoid hypoxic stimuli. Then, breathing frequency, P 0.1 , and minute ventilation (V E) were recorded from the ventilator, and an arterial blood sample was withdrawn. Thereafter we initiated the CO 2 response test by increasing dead space, maintaining the same ventilatory support, and when the exhaled CO 2 (measured through capnography) had increased by above 10 mm Hg, we again measured breathing frequency, P 0.1 , and V E, and withdrew another arterial blood sample. Once the CO 2 response test was finished, the added dead space was removed and the subject was returned to his original assisted ventilation mode.
We studied the following derived indices of CO 2 response test: the hypercapnic drive response, defined as the ratio of the change in P 0.1 (⌬P 0.1 ) to the change in PaCO 2 (⌬PaCO 2 ), and the hypercapnic ventilatory response, defined as the ratio of ⌬V E to ⌬PaCO 2 . The changes in V E, P 0.1 , and PaCO 2 were calculated as the difference between the value at the end of the CO 2 response test and the baseline value. P 0.1 was measured by means of the built-in system of the ventilator (Evita 2 Dura or Evita 4, Dräger, Lübeck, Germany), 23, 24 and P 0.1 was calculated as the mean of 5 measurements at each point of the study. 25 Arterial blood gases were measured with a blood gas analyzer (IL-1650, Instrument Laboratory, Izasa, Spain).
Data Collection and Definitions
We recorded the following clinical variables: sex, age, height, weight, presence of diabetes, the Simplified Acute Physiological Score II, duration of mechanical ventilation before the study day, number of tracheotomized subjects, ICU and in-hospital stay, and ICU and in-hospital mortality. The etiology of NMD and the main diagnosis in the ICU-AW subjects were also recorded. In subjects with NMD, arterial blood gases (when available) were recorded before initiating mechanical ventilation.
We considered the study day as the day that the CO 2 response test was performed. We considered a value Յ 26 Duration of mechanical ventilation before the study day was defined as the number of days between the beginning of mechanical ventilation and the day the CO 2 response test was performed. Subjects were followed until discharge from our 2 hospitals.
Statistical Analysis
Categorical data are expressed as number and percentages. Continuous variables are expressed as mean Ϯ standard deviation or as median and interquartile ranges (IQR). Differences between groups were compared with the paired t test or the Mann-Whitney test and chi-square test or Fisher exact test, when appropriate. We used linear regression to establish the association between P Imax and hypercapnic drive response and hypercapnic ventilatory response. We used the Kaplan-Meier method and the log-rank test to estimate differences in the duration of weaning between the groups of subjects and for the threshold value of hypercapnic drive response. Statistical analysis was performed with specific statistics software (SPSS 17.0, SPSS, Chicago, Illinois).
Results
The etiology of the NMD and the underlying diagnosis in ICU-AW subjects are summarized in Table 1 . We found no differences between the NMD and ICU-AW groups, except for the Simplified Acute Physiological Score II, the duration of mechanical ventilation before study day, and ICU and in-hospital stay (see Table 1 ). In 12 subjects with NMD we obtained a sample for measuring arterial blood gases before mechanical ventilation. Mean pH was 7.20 Ϯ 0.11 and PaCO 2 was 86 Ϯ 28 mm Hg. The other 4 NMD subjects received invasive mechanical ventilation before arterial blood samples were drawn.
Subjects with NMD had lower baseline PaO 2 /FIO 2 , breathing frequency, P 0.1 , and V E, and higher PaCO 2 than ICU-AW subjects, with no differences in pH, bicarbonate, and volume of added dead space (Table 2) . Inspiratory neuromuscular function evaluated by P Imax , hypercapnic drive response (⌬P 0.1 /⌬PaCO 2 ), and hypercapnic ventilatory response (⌬V E/⌬PaCO 2 ) were significantly lower in the NMD than in the ICU-AW subjects (see Table 2 and Fig. 1 ). Expiratory muscle strength evaluated by P Emax was low in both groups, without significant statistical differences (see Table 2 ). There was a weak association between P Imax and the hypercapnic drive response (r 2 ϭ 0.31, P Ͼ .001) and the hypercapnic ventilatory response (r 2 ϭ 0.15, P ϭ .01) (Fig. 2) . The duration of weaning, evaluated by Kaplan-Meier curves (Fig. 3) , was similar in both groups (log-rank ϭ 0.03, P ϭ .96). Eleven subjects (69%) in the NMD group and 9 subjects (35%) in the ICU-AW group had hypercapnic drive response Յ 0.19 cm H 2 O/mm Hg (Table 3) . When analyzed, each group, NMD or ICU-AW, according to the CO 2 response, weaning was shorter in subjects with hypercapnic drive response Ͼ 0.19 cm H 2 O/mm Hg than in subjects with hypercapnic drive response Յ 0.19 cm H 2 O/mm Hg, with significant differences in the ICU-AW group (log-rank ϭ 14.0, P Ͻ .001), but not in the NMD group (log-rank ϭ 2.1, P ϭ .14) (see Fig. 3 ). For both groups the duration of weaning was longer in subjects with hypercapnic drive response Յ 0.19 cm H 2 O/mm Hg (logrank ϭ 15.4, p Ͻ .001).
Discussion
The main results of the study were that the hypercapnic drive response was reduced in NMD patients recovering from acute hypercapnic respiratory failure, while it was preserved in most ICU-AW patients presenting with weaning failure. In both groups of subjects the duration of weaning was longer when the hypercapnic drive response was reduced. However, these affirmations should be considered with caution, since both groups were not comparable in all baseline characteristics, including the underlying cause of mechanical ventilation.
The acute respiratory failure in the NMD group was associated with respiratory muscle weakness, as shown by low values of P Imax and P Emax . However, a severe reduction of the hypercapnic drive response in the majority of subjects was also observed. These data suggest that the respiratory muscle weakness itself explained only part of the respiratory failure in the NMD subjects. The weak association between hypercapnic drive response and respiratory muscle weakness reflects the different contribution of each mechanism for a given subject. Eleven subjects (69%) of the NMD group had a hypercapnic drive response value Յ 0.19 cm H 2 O/mm Hg. The low mean value of hypercapnic drive response (0.24 Ϯ 0.05 cm H 2 O/mm Hg) of the 5 NMD subjects with hypercapnic drive response Ͼ 0.19 cm H 2 O/mm Hg may explain why there were no statistical differences in the duration of weaning among NMD subjects with hypercapnic drive response above and below the cutoff value. Although it is unknown which level of hypercapnic drive response should be considered clinically low, a cutoff value of Յ 0.19 cm H 2 O/mm Hg has recently been associated with prolonged weaning. 26 The ICU-AW subjects, differently from the NMD group, had higher baseline P 0.1 and were able to increase the P 0.1 with hypercapnic stimulation, in spite of presenting with quadriplegia. The mean hypercapnic drive response value found in these subjects was only moderately lower than that previously reported in healthy subjects, 0.6 Ϯ 0.5 cm H 2 O/mm Hg, 27 and only 9 subjects (35%) had a hypercapnic drive response value Յ 0.19 cm H 2 O/ mm Hg.
To our knowledge, only one study measured the hypercapnic drive response in NMD patients recovering from acute respiratory failure. 12 Contrary to our results, Borel et al 12 found that the hypercapnic drive response remained intact in 73 trials of spontaneous breathing performed in 4 patients with Guillain-Barré and 3 patients with myasthenia gravis. However, failed trials showed lower values of hypercapnic drive response, compared to successful trials, and, thus, those patients who failed the spontaneous breathing trial had low values of hypercapnic drive response, in agreement with our results.
Reduced hypercapnic drive response represents a reduction in sensitivity of chemoreceptors to chemical CO 2 stimuli. The cause of reduced sensitivity can be idiopathic in 10 -15% of healthy subjects, 27 or acquired in patients with acute or chronic diseases, as occurs in patients with diabetic autonomic neuropathy. In these patients it has been reported that there is a relationship between a predominant parasympathetic involvement and a reduced cerebrovascular CO 2 reactivity and reduced P 0.1 response to CO 2 . 28 Autonomic neuropathy or dysfunction has been described in many other diseases, including NMD 29 and multiple organ dysfunction syndrome. 30, 31 We hypothesize that autonomic neuropathy associated with a reduced sensitivity of chemoreceptors could explain the reduced hypercapnic drive response in most of our NMD and some ICU-AW subjects. In spite of that, autonomic neuropathy is not a clinical feature of ICU-AW patients 32 ; most of ICU-AW patients have multiple organ dysfunction syndrome, and this feature can play a role in the reduced CO 2 response we found. Additionally, other causes of autonomic neuropathy can be present. In our study, 4 out of 9 subjects with ICU-AW and hypercapnic drive response Յ 0.19 cm H 2 O/mm Hg had diabetes. Further studies are needed to confirm the hypothesis of association between autonomic neuropathy and reduced CO 2 response. Interestingly, and in favor of this hypothesis, autonomic instability and bulbar dysfunction predicted the development of neuromuscular respiratory paralysis in patients with Guillain-Barré syndrome. [33] [34] [35] A potential drawback of our study is based on the influence of sedatives in our results. Although both groups differed in the type and dose of sedatives, this is not likely to be determinant for our conclusions because the NMD subjects, who had a more blunted CO 2 response, received very short-acting sedatives within a median (IQR) of 2.5 (1-5) days of onset of mechanical ventilation, compared with ICU-AW, who received long-acting sedatives a median (IQR) of 18 (15-32) days.
Our study has several limitations. First, we studied a small number of subjects in each group, and, in addition, the NMD group was heterogeneous and both groups were not comparable in baseline characteristics. Therefore, it is necessary to perform larger trials of a more homogeneous population to confirm our results. Second, we measured P 0.1 through the ventilators, instead of with the conventional method. 36 The Evita ventilator shows a trend to overestimate high P 0.1 values and to underestimate low P 0.1 values. 24 However, CO 2 response evaluates the V E and P 0.1 changes induced by a CO 2 increase, not the absolute V E and P 0.1 values, so the systematic error may be reduced. And, third, we have not performed autonomic function tests to evaluate the activity of the autonomic nervous system.
Conclusions
In conclusion, subjects with acute hypercapnic respiratory failure due to NMD had reduced hypercapnic drive response, compared to quadriplegic subjects secondary to ICU-AW. The duration of weaning was longer in subjects with reduced hypercapnic drive response. 
